WW International corrects Q1 subscriber metrics; Clinical subscribers overstated by 4k

WW INTERNATIONAL, INC.

Clinical End of Period Subscribers corrected to 87k from 91k; Total End of Period Subscribers to 4.004M from 4.008M.
Clinical Paid Weeks corrected to 1.038M from 1.056M; Total Paid Weeks to 51.782M from 51.799M.
Error stemmed from double-counting of subscribers transitioning between Clinical and other plans; reporting framework revised.
No other financial information, including revenues and EPS, was affected.
FY 2024 guidance reaffirmed: total subscribers 3.8-4.0M, Clinical subscribers 140k-160k, and expectation for subscription revenue growth.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

WW INTERNATIONAL, INC. reported first quarter ended March 30, 2024 results: revenue $206.5 million, net income ($347.9), EPS ($4.39).

Period: first quarter ended March 30, 2024
Revenue: $206.5 million
Net income: ($347.9)
EPS: ($4.39)
Result: reported results

Exact text from the filing

as applicable. No other information was incorrectly presented. • End of Period Subscribers of 4.0 million, including 87 thousand End of Period Clinical Subscribers • Revenues of $206.5 million • Gross margin of 66.7%; excluding the net impact of restructuring charges related to prior year restructuring plans, adjusted gross margin of 67.9% • Operating Loss of $269.3

View on SEC.gov

1053 earnings releases filed in the last 30 days. Browse all earnings releases →

WW INTERNATIONAL, INC. filing history →

Source: SEC EDGAR

accession 0001193125-24-135310

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.